Author

Nafsika Forte

Innovative Genomics InstituteORCID 0000-0002-8550-160XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Belen E. Altamirano PoblanoiD· 1 shared Daniel K. NomuraiD· 1 shared Flor A. Gowans· 1 shared Ingrid E. WertziD· 1 shared Justin Hatcher· 1 shared Oscar W. Huang· 1 shared Yangzhi WangiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Belen E. Altamirano PoblanoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BiochemistryJournal of the American Chemical SocietyPeer-reviewedJun 6, 2024

Covalent Degrader of the Oncogenic Transcription Factor β-Catenin

Flor A. Gowans, Nafsika Forte, Justin Hatcher…·Daniel K. Nomura

This paper identifies a covalent degrader, EN83, that targets and degrades β-catenin by covalently binding to four cysteine residues, demonstrating a strategy to overcome the 'undruggable' challenge of transcription factors.

31 citations

humanproteomics

𝕏 PostBluesky